These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34505827)

  • 1. Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine.
    Stevenson C; Youn JH; Hayney MS; David C
    Hum Vaccin Immunother; 2021 Nov; 17(11):4567-4577. PubMed ID: 34505827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.
    Girndt M; Houser P; Manllo-Karim R; Ervin JE; Charytan C; Chow S; Symonian-Silver M; Lehrner L; Linfert D; Shemin D; Michelsen A; Xie F; Janssen RS
    Vaccine; 2023 May; 41(20):3224-3232. PubMed ID: 37085451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination.
    Janssen RS; Bruxvoort K; Jacobsen SJ; Slezak J; David C; Hyer R; Poland GA
    Vaccine; 2021 Sep; 39(39):5666-5672. PubMed ID: 34404556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis.
    Manley HJ; Aweh G; Frament J; Ladik V; Lacson EK
    Nephrol Dial Transplant; 2023 Feb; 38(2):447-454. PubMed ID: 35150277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing Hepatitis B Virus Infection Among U.S. Military Personnel: Potential Impact of a 2-Dose Versus 3-Dose Vaccine on Medical Readiness.
    Oelschlager KA; Termini MS; Stevenson C
    Mil Med; 2023 Jul; 188(7-8):e2067-e2073. PubMed ID: 36525511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study.
    Girndt M; Plüer M; Dellanna F; Michelsen AK; Beige J; Toussaint K; Wehweck HJ; Koch M; Hafezi Rachti S; Faust J; Bosselmann HP; Witzke O; Janssen RS;
    Hum Vaccin Immunother; 2022 Nov; 18(6):2136912. PubMed ID: 36269938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.
    Schillie S; Murphy TV; Sawyer M; Ly K; Hughes E; Jiles R; de Perio MA; Reilly M; Byrd K; Ward JW;
    MMWR Recomm Rep; 2013 Dec; 62(RR-10):1-19. PubMed ID: 24352112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant.
    Champion CR
    Ann Pharmacother; 2021 Jun; 55(6):783-791. PubMed ID: 32988213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Number of Doses With Hepatitis B Vaccine Series Completion in US Adults.
    Bruxvoort K; Slezak J; Huang R; Ackerson B; Sy LS; Qian L; Reynolds K; Towner W; Solano Z; Mercado C; Hyer R; Janssen R; Jacobsen SJ
    JAMA Netw Open; 2020 Nov; 3(11):e2027577. PubMed ID: 33252692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations.
    Hirst A; Hyer RN; Janssen RS
    Vaccine; 2021 Jul; 39(33):4733-4741. PubMed ID: 34030898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
    Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
    Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV.
    Reilly-Evans B; Dudzik B; Costlow DJ; Hartmann C; Khalsa AM; Kassis C; Zmarlicka MT
    Open Forum Infect Dis; 2023 Jun; 10(6):ofad267. PubMed ID: 37389224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus.
    Marks KM; Kang M; Umbleja T; Avihingsanon A; Sugandhavesa P; Cox AL; Vigil K; Perazzo H; Price JC; Katsidzira L; Vernon C; Alston-Smith B; Sherman KE;
    Clin Infect Dis; 2023 Aug; 77(3):414-418. PubMed ID: 37017075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study.
    Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK
    Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undervaccination with hepatitis B vaccine: missed opportunities or choice?
    Jiles RB; Daniels D; Yusuf HR; McCauley MM; Chu SY
    Am J Prev Med; 2001 May; 20(4 Suppl):75-83. PubMed ID: 11331136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heplisav-B vaccination for the prevention of hepatitis B virus infection in adults in the United States.
    Splawn LM; Bailey CA; Medina JP; Cho JC
    Drugs Today (Barc); 2018 Jul; 54(7):399-405. PubMed ID: 30090877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis.
    Awad AM; Ntoso A; Connaire JJ; Hernandez GT; Dhillon K; Rich L; Henderson H; Lynn R; Hyer RN; Xie F; Erby K; Janssen RS;
    Vaccine; 2021 Jun; 39(25):3346-3352. PubMed ID: 34001345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.
    Van Den Ende C; Marano C; Van Ahee A; Bunge EM; De Moerlooze L
    Expert Rev Vaccines; 2017 Aug; 16(8):811-832. PubMed ID: 28573913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult immunization against hepatitis B: Does the number of jabs matter?
    Oster G; Bornheimer R; Ottino K; Stevenson C; Lewin C; Janssen R
    Vaccine; 2022 Jun; 40(26):3597-3604. PubMed ID: 35570079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
    Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
    Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.